Tempus Labs (company)

Tempus Labs (company)

Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.

Tempus is an artificial intelligence company developing new treatment plans for patients with cancer by collecting molecular data. The information is then made available to physicians through an operating system that allows doctors to make data-driven treatment decisions with their patients. Tempus was founded by Eric Lefkosky, the co-founder of Groupon, in 2015.

Tempus uses genomic tests to analyze DNA, RNA, and proteomic data to understand a patient's tumor at the molecular level to identify treatment options that are patient-centric. The Tempus platform analyzes thousands of clinical and molecular data points, connecting physicians with up-to-date treatment options and insights for patients based on their molecular profile.

COVID-19 Response:

Tempus launched a diagnostic polymerase chain reaction (PCR) test for COVID-19. Tempus' CAP-accredited/CLIA-certified labs in Chicago and Atlanta are supporting the acceleration of testing in the U.S, and expect to test approximately 12,000 patients daily across both labs, with the ability to scale further if needed.

Tempus offers an on-demand virtual case review system that provides clinical support to physicians and care teams in a timely manner. Tempus' Medical Affairs team is available to answer patient report questions in real-time in a secure portal. In addition, Tempus now offers a variety of telehealth support services specific to COVID-19 if needed.

Tempus launched a large research collaboration to structure data for up to 50,000 COVID-19 positive patients. Tempus is partnering with providers to collect data on COVID-19 patients, which Tempus is structuring and de-identifying without cost. In addition, Tempus expects to perform full transcriptomic profiling of approximately 10,000 patients within the cohort. All data will be shared with all participating institutions without restriction.

Timeline

December 11, 2019

Tempus acquired AKESOgen on Dec 11, 2019.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Tempus series F round
200,000,000
May 2019
8 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Colette Freeman

Chief of People Officer

Eric Lefkofsky

Founder & CEO

Erik Phelps

Chief Administrative and Legal officer

Kim Blackwell

Chief Medical Officer

Ryan Fukushima

Chief of Operations Officer

Shane Colley

Chief Technical Officer

Vanessa Rollings

Chief Financial Officer

Further reading

Title
Author
Link
Type
Date

Chicago precision medicine startup Tempus nabs $200M for expansion - MedCity News

Erin Dietsche

Web

May 30, 2019

Chicago's Tempus Labs Signs 5 Year Lease in Manhattan | CoStar

Natalie Silady

Web

June 15, 2020

Following $110M fundraise, Tempus reveals mobile app to give doctors access to clinical data - MedCity News

Erin Dietsche

Web

September 19, 2018

Health Data Startup Tempus Accused of Poaching Top Executive

Mike Leonard

Web

December 4, 2019

Lefkofsky's Tempus raises $100 million to expand beyond cancer

John Pletz

Web

March 13, 2020

Tempus Acquires Commercial Lab, Precision Medicine Services Provider Akesogen

Web

December 13, 2019

Tempus closed $200 million funding round to reach $3 billion valuation - Business Insider

Zoë LaRock

Web

May 31, 2019

Tempus: Health start-up backed by Groupon co-founder joins the fight against Covid-19

Daniel Bukszpan

Web

June 17, 2020

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
BioSpace
May 30, 2020
BioSpace
Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, introduced a series of offerings designed to both advance vital research and support physicians in treating cancer patients, despite the challenges of the COVID-19 pandemic.
Business Standard Editorial Comment
May 14, 2020
@bsindia
MPC will have to work with an incomplete inflation picture
Connie Loizos
May 31, 2019
TechCrunch
When serial entrepreneur Eric Lefkofsky grows a company, he puts the pedal to the metal. When in 2011 his last company, the Chicago-based coupons site Groupon, raised $950 million from investors, it was the largest amount raised by a startup ever. It was just over three years old at the time, and it went public [...]

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.